A Trial to Evaluate the Efficacy, Safety, PK, and PD of HP515 in Non - Alcoholic Fatty Liver Disease ( NASH/MASH )

Abroad (travel likely)RecruitingPHASE2

Conditions

NAFLD (Non-alcoholic Fatty Liver Disease)

Simple summaryAI-assisted

This summary is produced by a language model and is experimental. It may be incomplete or inaccurate and is not a substitute for professional medical advice.

Locations

Beijing Tsinghua Changgung Hospital, Beijing, Beijing Municipality, China
Contact: Study coordinator (Liu Man Ting LMT Liu) · IRB@btch.edu.cn · +86-01056118567
Chengdu Seventh People's Hospital, Chengdu, Sichuan, China
Contact: Study coordinator (Liu JingYu LJY chief physician) · liujy92@163.com · +86-13540087274
Contact: Study coordinator (chief physician)

View source on ClinicalTrials.gov

Similar trials

Other trials that are currently recruiting and may be relevant based on condition, treatment, phase, or location

Randomized Double Blinded Placebo-Controlled w/Semaglutide to Prevent Weight Gain After Liver Transplant

NAFLD

Abroad (travel likely)RecruitingPHASE2

Richmond, United States

Study of the Efficacy and Safety of Nicotinamide in Patients With Liver Fibrosis (NICOFIB)

Fatty Liver · Obesity · Hepatic Fibrosis

Abroad (travel likely)RecruitingPHASE2

Barcelona, Spain

A Pivotal Clinical Study to Investigate Efimosfermin Alfa in Participants With Biopsy-confirmed F2- or F3-stage MASH

Non-alcoholic Fatty Liver Disease

Abroad (travel likely)RecruitingPHASE3

Arcadia, United States · Covina, United States

Effect of Amino Acids on Hepatic Fat Content in Adolescents (AMINOS Study)

Hepatic Steatosis · NAFLD · Adolescent Obesity

Abroad (travel likely)RecruitingPHASE3

Aurora, United States